220P Oral selective estrogen receptor degraders for metastatic hormone receptor-positive, HER2 negative breast cancer according to ESR1 mutation: A systematic review and meta-analysis of randomized control trials
Autor: | Novello, R.G. Santiago, Lobo, M., Vilbert, M. Silveira, Sanches, S.M., Cesca, M.G. |
---|---|
Zdroj: | In ESMO Open May 2023 8(1) Supplement 4 |
Databáze: | ScienceDirect |
Externí odkaz: |